Molecular profiling of biliary tract cancer: a target rich disease

Journal of Gastrointestinal Oncology

Milind Javle¹  Apurva Jain¹ 

[1] Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USADepartment of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USADepartment of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA

关键词: Next-generation sequencing (NGS);    biliary tract cancers (BTCs);    overall survival;    ARID1A;    isocitrate dehydrogenase 1 or 2 (IDH1/2);    FGFR2;    targeted therapy;   

DOI  :  10.21037/jgo.2016.09.01

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown